Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07279740 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Combined Brain Stimulation and Methylphenidate Treatment for Apathy in Dementia

Study acronym: PRIME
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This study evaluates whether the combined treatment of methylphenidate and non-invasive brain stimulation, called intermittent theta burst stimulation, can effectively treat apathy in individuals with Alzheimer's disease or mixed AD/vascular dementia
Trial Details
NCT Number NCT07279740
Lead Sponsor Sunnybrook Health Sciences Centre
Collaborators: Alzheimer Society of Canada, Sunnybrook Research Institute, Brain Canada
Conditions
(from sponsor)		 Alzheimer s Disease, Alzheimer Dementia (AD), Alzheimer Dementia, Alzheimer Disease, Apathy, Apathy in Dementia
Related terms Alzheimer Disease, Dementia, Lethargy
Enrollment 12 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov